| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2014 | Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-kappaB-mediated antiapoptotic pathway. | Huang, CK; Yang, CY; Jeng, YM; Chen, CL; Wu, HH; Chang, YC; Ma, C; Kuo, WH; Chang, KJ; Shew, JY; Lee, WH | Oncogene 33(23), 2968-77 | | | |
| 2021 | Characterization of Initial Key Steps of IL-17 Receptor B Oncogenic Signaling for Targeted Therapy of Pancreatic Cancer | Wu, HH; Tsai, LH; Huang, CK; Hsu, PH; Chen, MY; Chen, YI; Hu, CM ; Shen, CN ; Lee, CC; Chang, MC; Chang, YT; Tien, YW; Jeng, YM; Lee, EYP; Lee, WH | Science Translational Medicine 13(583), eabc2823 | | | |
| 2009 | Microwave-assisted stereoselective α-2-deoxyglycosylation of hex-1-en-3-uloses | Lin, HC; Wu, HH; Lin, ZP; Lin, CY; Lin, CH ; Chen, KL; Wong, FF | Tetrahedron Letters 50(52), 7223-7234 | | | |
| 2016 | Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma. | Sung, PL; Jan, YH; Lin, SC; Huang, CC; Lin, H; Wen, KC; Chao, KC; Lai, CR; Wang, PH; Chuang, CM; Wu, HH; Twu, NF; Yen, MS; Hsiao, M; Huang, CF | Oncotarget Jan 26;7(4):4036-47 | | | |
| 2012 | Structural Delineation of MDC1-FHA Domain Binding with CHK2-pThr68 | Wu, HH; Wu, PY; Huang, KF ; Kao, YY; Tsai, MD | Biochemistry 51(2), 575-577 | | | |
| 2004 | Sub-fragments of the envelope gene are highly protective against the Japanese encephalitis virus lethal infection in DNA priming-protein boosting immunization strategies. | Wu, HH; Chen, CT; Lin, YL; Lee, ST. | Vaccine 22(5-6), 793-800 | | | |
| 2015 | Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines | Wu, HH; Hwang-Verslues, WW; Lee, WH; Huang, CK; Wei, PC; Chen, CL; Shew, JY; Lee, EY; Jeng, YM; Tien, YW; Ma, C; Lee, WH | Journal of Experimental Medicine 212(3), 333-349 | | | |
| 2015 | Targeting interleukin-17 receptors. | Lee, WH; Wu, HH; Huang, CK | Oncotarget 6(21), 18244-5 | | | |
